Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain

ASN Neuro

Volumn 2, Issue 4, 2010, Pages 219-231

  Tatar, Carrie L ^a   Appikatla, Sunita ^a   Bessert, Denise A ^a   Paintlia, Ajaib S ^b   Singh, Inderjit ^b   Skoff, Robert P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Inflammation; Microglia; Myelin; Oligodendrocyte; Pelizaeus merzbacher disease; Proteolipid protein

Indexed keywords

CYTOKINE; INTERLEUKIN 6; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MARKER; DNA SEQUENCE; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; GRAY MATTER; INFLAMMATION; MALE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PREDICTION; SPECIES COMPARISON; UPREGULATION; WHITE MATTER;

EID: 77958457229     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20100016     Document Type: Article

References (73)

1. Anderson TJ, Schneider A, Barrie JA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave KA, Griffiths IR (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394:506-519.
2. Anderson TJ, Klugmann M, Thomson CE, Schneider A, Readhead C, Nave KA, Griffiths IR (1999) Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication. Ann NY Acad Sci 883:234-246.
3. Baraczka K, Nékám K, Pozsonyi T, Szüts I, Ormos G (2004) Investigation of cytokine (tumor necrosis factor alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol 11:37-42.
4. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-1244.
5. Bessert DA, Skoff RP (1999) High-resolution in situ hybridization and TUNEL staining with free-floating brain sections. J Histochem Cytochem 47:693-702.
6. Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77-98.
7. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62:723-732.
8. Boison D, Büssow H, D'Urso D, Müller HW, Stoffel W (1995) Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J Neurosci 15:5502-5513.
9. Bokhari SM, Yao H, Bethel-Brown C, Fuwang P, Williams R, Dhillon NK, Hegde R, Kumar A, Buch SJ (2009) Morphine enhances Tat-induced activation in murine microglia. J Neurovirol 22:1-10.
10. Bradl M, Bauer J, Inomata T, Zielasek J, Nave KA, Toyka K, Lassmann H, Wekerle H (1999) Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol 97:595-606.
11. Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41:242-247.
12. Campagnoni AT, Skoff RP (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol 11:74-91.
13. Cerghet M, Bessert DA, Nave KA, Skoff RP (2001) Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways. J Neurocytol 30:841-855.
14. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5:46.
15. Di Napoli MD, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Sander K, Smith CJ, Stefanini A, Weber D (2005) Evaluation of c-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stoke 36:1316-1329.
16. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF (1991) Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest, 64:135-156.
17. Dissing-Olesen L, Ladeby R, Nielsen H, Toft-Hansen H, Dalmau I, Finsen B (2007) Axonal lesion-induced microglial proliferation and microglial cluster formation in the mouse. Neurosci 149:112-122.
18. Duncan I, Hammang J, Trapp B (1987) Abnormal compact myelin in the myelin-deficient rat: absence of proteolipid protein correlates with a defect in the intraperiod line. Proc Natl Acad Sci USA 84:6287-6291.
19. Edgar JM, McCulloch MC, Montague P, Brown AM, Thilemann S, Pratola L, Gruenenfelder FI, Griffiths IR, Nave KA (2010) Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med 2:42-50.
20. Garbern JY, Cambi F, Lewis R, Shy M, Sima A, Kraft G, Vallat JM, Bosch EP, Hodes ME, Dlouhy S, Raskind W, Birt T, and Macklin W (1999) Peripheral neuropathy caused by proteolipid protein gene mutations. Ann NY Acad Sci 883:351-365.
21. Garbern, JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, Van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
22. Gonzalez-Scarano, F. and G. Baltuch (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-40.
23. Gorman MP, Golomb MR, Walsh LE, Hobson GM, Garbern JY, Kinkel RP, Darras BT, Urion DK, Eksioglu YZ (2007) Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation. Neurology 68:1305-1307.
24. Gow A, Southwood CM, Lazzarini RA (1998) Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925-934.
25. Graeber M, López-Redondo F, Ikoma E, Ishikawa M, Imai Y, Nakajima K, Krutzberg GW, Kohsaka S (1998) The microglia/macrophage response in the neonatal rat facial nucleus following axotomy. Brain Res 813:241-253.
26. Gray E, Thomas T, Betmouni S, Scolding N, Love S (2008). Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathology 18:86-95
27. Griffiths I, Klugmann M, Anderson T, Thomson C, Vouyiouklis D, Nave KA (1998) Current concepts of PLP and its role in the nervous system. Microsc Res Tech 41:344-358.
28. Gudz TI, Schneider TE, Haas TA, Macklin WB (2002) Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes. J Neurosci 22:7398-7407.
29. Gyoneva S, Orr AG, Traynelis SF (2009) Differential regulation of microglial motility by ATP/ADP and adenosine. Parkinsonism Relat Disord 15:S195-S199.
30. Hodes ME, Pratt VM, Dlouhy SR (1993) The genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 15:383-394.
31. Hüttemann M, Zhang Z, Mullins C, Bessert D, Lee I, Nave KA, Appikatla S, Skoff RP (2009) Different proteolipid protein mutants exhibit unique metabolic defects. ASN Neuro 1:e00014
32. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S (1996) A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 224:855-862.
33. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, Wiendl H, Nave KA, Martini R (2006) Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. Neurobiol Dis 26:8206-8216.
34. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microgliaspecific localisation of a novel calcium binding protein, Iba1. Mol Brain Res 57:1-9.
35. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427-442.
36. Kawashita E, Tsuji D, Kawashima N, Nakayama K, Matsuno H, Itoh K (2009) Abnormal production of macrophage inflammatory protein-1alpha by microglial cell lines derived from neonatal brains of Sandhoff disease model mice. J Neurochem 109:1215-1224.
37. Knapp PE (1996) Proteolipid protein: is it more than just a structural component of myelin? Dev Neurosci 18:297-308.
38. Knapp PE, Booth CS, Skoff RP (1993) The pH of jimpy glia is increased: intracellular measurements using fluorescent laser cytometry. Int J Dev Neurosci 11:215-226.
39. Knerlich-Lukoschus F, von der Ropp-Brenner B, Lucius R, Mehdorn HM, Held- Feindt J (2010) Chemokine expression in the white matter spinal cord precursor niche after force-defined spinal cord contusion injuries in adult rats. Glia 58:916-931.
40. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
41. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705-2712.
42. Lambert C, Ase AR, Séguéla P, Antel JP (2010) Distinct migratory and cytokine responses of human microglia and macrophages to ATP. Brain Behav Immun, doi:10.1016/j.bbi.2010.02.010.
43. Macklin WB, Campagnoni CW, Deininger PL, Gardinier MV (1987) Structure and expression of the mouse myelin proteolipid protein gene. J Neurosci Res 18:383-394.
44. Macklin WB, Gardinier MV, Obeso ZO, King KD, Wight PA (1991) Mutations in the myelin proteolipid protein gene alter oligodendrocyte gene expression in jimpy and jimpy msd mice. J Neurochem 56:163-171.
45. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA (1993) Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 36:315-324.
46. Matsumoto Y, Ohmori K, Fujiwara M (1992) Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J Neuroimmunol 37:23-33.
47. McGeer PL Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7:84-92.
48. Monif M, Reid CA, Powell KL, Smart ML, Williams DA (2009) The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 29:3781-3791.
49. Nadon NL, West M (1998) Myelin proteolipid protein: function in myelin structure is distinct from its role in oligodendrocyte development. Dev Neurosci 20:533-539.
50. Napoli I, Kierdorf K, Neumann H (2009) Microglial precursors derived from mouse embryonic stem cells. Glia 57:1660-1671.
51. Navikas V, Link H (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45:322-333.
52. Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389-400.
53. Puthussery T, Fletcher E (2009) Extracellular ATP induces retinal photoreceptor apoptosis through activation of purinoceptors in rodents. J Comp Neurol 513:430-440.
54. Readhead C, Schneider A, Griffiths I, Nave KA (1994) Premature arrest of myelinformation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
55. Regis S, Grossi S, Lualdi S, Biancheri R, Filocamo M (2005) Diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene copy number by real-time PCR. Neurogenetics 6:73-78.
56. Santos AM, Martin-Oliva D, Ferrer-Martin RM, Tassi M, Calvente R, Sierra A, Carrasco MC, Marin-Teva JL, Navascués J, Cuadros MA (2010) Microglial response to light-induced photoreceptor degeneration in the mouse retina. J Comp Neurol 518:477-492.
57. Skoff RP (1975) The fine structure of pulse labeled (3-H-thymidine cells) in degenerating rat optic nerve. J Comp Neurol 161:595-611.
58. Skoff RP (1976) Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia. Nature 264:560-562.
59. Skoff RP, Knapp PE (1990) Expression of the jimpy phenotype in relation to proteolipid protein appearance. Ann NY Acad Sci 605:122-134.
60. Skoff RP, Bessert DA, Cerghet M, Franklin MJ, Rout UK, Nave KA, Carlock L, Ghandour MS, Armant DR (2004a) The myelin proteolipid protein gene modulates apoptosis in neural and non-neural tissues. Cell Death Diff 11:1247-1257
61. Skoff RP, Saluja I, Bessert D, Yang X (2004b) Analyses of proteolipid protein mutants show levels of proteolipid protein regulate oligodendrocyte number and cell death in vitro and in vivo. Neurochem Res 29:2095-2103.
62. Stoffel W, Giersiefen H, Hillen H, Schroeder W, Tunggal B (1985) Amino-acid sequence of human and bovine brain myelin proteolipid protein (lipophilin) is completely conserved. Biol Chem Hoppe-Seyler 366:627-635.
63. Szalai AJ, Nataf S, Hu XZ, Barnum SR (2002) Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human Creactive protein. J Immunol 168:5792-5797.
64. Thomas WE (1992) Brain macrophages: evaluation of microglia and their functions. Brain Res Rev 17:61-74.
65. Tonchev AB, Yamashima T, Zhao L, Okano H (2003) Differential proliferative response in the postischemic hippocampus, temporal cortex, and olfactory bulb of young adult macaque monkeys. Glia 42:209-224.
66. Vela J, Dalmau I, Acrín L, González B, Castellano B (1995) Microglial cell reaction in the gray and white matter in spinal cords from jimpy mice. An enzyme histochemical study at the light electron microscope level. Brain Res 694:287-298.
67. Vela J, Dalmau I, González, B, Castellano B (1996) Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse. Brain Res 712:134-142.
68. Vladic A, Horvat G, Vukadin S, Sucic Z, Simaga S (2002) Cerebrospinal fluid and serum protein levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6-R gp80) in multiple sclerosis patients. Cytokine 20:86-89.
69. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P (2005) Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64:1101-1107.
70. Wojtera M, Sikorska B, Sobow T, Liberski PP (2005) Microglial cells in neurodegenerative disorders. Folia Neuropathol 43:311-321.
71. Yamada M, Ohsawa K, Imai Y, Kohsaka S, Kamitori S (2006) X-ray structures of the microglia/macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding. J Mol Biol 364:449-457.
72. Yang X, Skoff RP (1997) Proteolipid protein regulates the survival and differentiation of oligodendrocytes. J Neurosci 17:2056-2070.
73. Zhang F, Vadakkan K, Kim S, Wu L, Shang Y, Zhuo M (2008) Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse. Mol Pain 4:15.